image
UroGen Pharma Ltd. URGN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 9.97
-0.103 %
$ 460 M
Market Cap
-3.26
P/E
Price Target Average
276.13%
Revenue Forecast Estimate
70.88%
EBIT Estimate
--66.21%
Net Income Estimate
38.70%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets UroGen Pharma Ltd.
image
Wall Street analysts predict an average 1-year price target for URGN of $37.5 , with forecasts ranging from a low of $22 to a high of $60 .
URGN Lowest Price Target Wall Street Target
22 USD 120.66%
URGN Average Price Target Wall Street Target
37.5 USD 276.13%
URGN Highest Price Target Wall Street Target
60 USD 501.81%
Price
Max Price Target
Min Price Target
Average Price Target
60605050404030302020101000Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart URGN

image
$800.0m$800.0m$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.020172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart URGN

image
$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)($700.0m)($700.0m)($800.0m)($800.0m)20172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart URGN

image
$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)20172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029